SGMT Sagimet Biosciences Inc.
Healthcare$7.26+0.00%OpenMarket Cap: $236.7M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
2.25
P/S
0.00
EV/EBITDA
-3.99
DCF Value
$1.05
FCF Yield
-17.2%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-37.6%
ROA
-40.4%
ROIC
-47.5%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $0.00 | NaN% | $-11.7M | $-10.7M | $— | — |
| Q4 null | $0.00 | NaN% | $-10.8M | $-9.6M | $— | — |
| FY null | $0.00 | NaN% | $-56.9M | $-51.0M | $— | — |
| Q3 null | $0.00 | NaN% | $-14.3M | $-12.9M | $— | — |
| Q2 null | $0.00 | NaN% | $-11.9M | $-10.4M | $— | — |
| Q1 null | $0.00 | NaN% | $-19.9M | $-18.2M | $— | — |
| Q4 null | $0.00 | NaN% | $-18.2M | $-16.2M | $— | — |
| FY null | $0.00 | NaN% | $-54.5M | $-45.6M | $— | — |
| Q3 null | $0.00 | NaN% | $-16.9M | $-14.6M | $— | — |
| Q2 null | $0.00 | NaN% | $-10.6M | $-8.1M | $— | — |
| Q1 null | $0.00 | NaN% | $-8.8M | $-6.6M | $— | — |
| Q4 2023 | $0.00 | NaN% | $-9.5M | $-8.2M | $-0.45 | — |